Pleurodesis using talc slurry.

PubWeight™: 2.29‹?› | Rank: Top 2%

🔗 View Article (PMID 7774299)

Published in Chest on August 01, 1994

Authors

L Kennedy1, V W Rusch, C Strange, R J Ginsberg, S A Sahn

Author Affiliations

1: Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, USA.

Articles citing this

BTS guidelines for the management of spontaneous pneumothorax. Thorax (2003) 6.38

BTS guidelines for the management of malignant pleural effusions. Thorax (2003) 2.24

Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion. Chest (2005) 1.89

Pleural effusion. Postgrad Med J (2005) 1.31

Management of recurrent malignant pleural effusion with chemical pleurodesis. Surg Today (2005) 0.91

Pleural procedures in the management of malignant effusions. Ann Thorac Med (2017) 0.90

Pleurodesis in patients with malignant pleural effusions: talc slurry or bleomycin? Results of a prospective randomized trial. World J Surg (2004) 0.83

Pleural effusions in children undergoing cardiac surgery. Ann Pediatr Cardiol (2010) 0.80

The effect of silver nitrate pleurodesis after a failed thoracoscopic talc poudrage. Biomed Res Int (2013) 0.78

Ultrastructural acute features of active remodeling after chemical pleurodesis induced by silver nitrate or talc. Lung (2005) 0.77

Pleurodesis induced by talc or silver nitrate: evaluation of collagen and elastic fibers in pleural remodeling. Lung (2006) 0.76

Surgical and other invasive approaches to recurrent pleural effusion with malignant etiology. Support Care Cancer (2008) 0.76

Update on pleural diseases--2007. Ann Thorac Med (2007) 0.76

Talc pleurodesis. Talc slurry vs talc poudrage. Chest (1995) 0.75

Role of talc modulation on cytokine activation in cancer patients undergoing pleurodesis. Pulm Med (2012) 0.75

Three comments regarding talc slurry for pleurodesis. Chest (1995) 0.75

Do concomitant ascites influence the effectiveness of palliative surgical management of pleural effusion in patients with malignancies? World J Surg (2009) 0.75

Efficacy of posterior fixation suture augmented with talc or doxycycline. Graefes Arch Clin Exp Ophthalmol (2010) 0.75

Articles by these authors

Management of spontaneous pneumothorax: an American College of Chest Physicians Delphi consensus statement. Chest (2001) 5.94

An endoscopic biopsy protocol can differentiate high-grade dysplasia from early adenocarcinoma in Barrett's esophagus. Gastroenterology (1993) 5.41

Long-term results of lung metastasectomy: prognostic analyses based on 5206 cases. J Thorac Cardiovasc Surg (1997) 4.47

Chemical pleurodesis for malignant pleural effusions. Ann Intern Med (1994) 4.14

Utility of a lung biopsy for the diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2001) 3.69

Esophageal perforation: a continuing challenge. Ann Thorac Surg (1992) 3.31

Incidence of local recurrence and second primary tumors in resected stage I lung cancer. J Thorac Cardiovasc Surg (1995) 3.31

Concurrent cisplatin/etoposide plus chest radiotherapy followed by surgery for stages IIIA (N2) and IIIB non-small-cell lung cancer: mature results of Southwest Oncology Group phase II study 8805. J Clin Oncol (1995) 2.89

Thoracic endometriosis syndrome: new observations from an analysis of 110 cases. Am J Med (1996) 2.73

Talc pleurodesis for the treatment of pneumothorax and pleural effusion. Chest (1994) 2.67

Airway obstruction arising from blood clot: three reports and a review of the literature. Chest (1999) 2.56

A phase II trial of surgical resection and adjuvant high-dose hemithoracic radiation for malignant pleural mesothelioma. J Thorac Cardiovasc Surg (2001) 2.54

Worldwide esophageal cancer collaboration. Dis Esophagus (2009) 2.41

Endobronchial lesions in HIV-infected individuals. Chest (1994) 2.26

Use of pooled DNA samples to detect linkage disequilibrium of polymorphic restriction fragments and human disease: studies of the HLA class II loci. Proc Natl Acad Sci U S A (1985) 2.19

Complication of central venous catheter insertion: fragmentation of a guidewire with pulmonary artery embolism. Crit Care Med (1991) 2.19

Chest tubes. Indications, technique, management and complications. Chest (1987) 2.15

Pulmonary metastases from soft tissue sarcoma: analysis of patterns of diseases and postmetastasis survival. Ann Surg (1999) 2.09

Thymoma: a multivariate analysis of factors predicting survival. Ann Thorac Surg (1995) 2.06

Carcinomatous involvement of the pleura: an analysis of 96 patients. Am J Med (1977) 2.01

Pleural diseases related to metastatic malignancies. Eur Respir J (1997) 1.97

Primary sarcomas of the mediastinum: results of therapy. J Thorac Cardiovasc Surg (1998) 1.96

Role of video-assisted thoracic surgery in the treatment of pulmonary metastases: results of a prospective trial. Ann Thorac Surg (1996) 1.91

Thymic carcinoma: current staging does not predict prognosis. J Thorac Cardiovasc Surg (1998) 1.79

Pericardiocentesis and intrapericardial sclerosis: effective therapy for malignant pericardial effusions. Ann Thorac Surg (1997) 1.78

Thoracentesis: a safe procedure in mechanically ventilated patients. Ann Intern Med (1990) 1.75

Medical management and therapy of bronchopleural fistulas in the mechanically ventilated patient. Chest (1990) 1.73

Modern thirty-day operative mortality for surgical resections in lung cancer. J Thorac Cardiovasc Surg (1983) 1.71

Proposed revision of the staging classification for esophageal cancer. J Thorac Cardiovasc Surg (1998) 1.69

Critical illness in pregnancy. An analysis of 20 patients admitted to a medical intensive care unit. Chest (1993) 1.69

Primary bony and cartilaginous sarcomas of chest wall: results of therapy. Ann Thorac Surg (1992) 1.68

The clinician's perspective on pneumothorax management. Chest (1997) 1.65

Treatment of spontaneous pneumothorax: a more aggressive approach? Chest (1997) 1.62

Prospective evaluation of unilateral adrenal masses in patients with operable non-small-cell lung cancer. Impact of magnetic resonance imaging. J Thorac Cardiovasc Surg (1994) 1.57

The differential diagnosis of pleural effusions. West J Med (1982) 1.55

Technique of successful lung transplantation in humans. J Thorac Cardiovasc Surg (1987) 1.54

Pulmonary manifestations of systemic lupus erythematosus: review of twelve cases of acute lupus pneumonitis. Medicine (Baltimore) (1975) 1.54

Morbidity and mortality after neoadjuvant therapy for lung cancer: the risks of right pneumonectomy. Ann Thorac Surg (2001) 1.49

Management of malignant pleural effusions. Eur Respir J (2001) 1.48

Hypothyroidism and pleural effusions. Chest (1990) 1.48

Biliopleural fistula as a complication of percutaneous biliary drainage: experimental evidence for pleural inflammation. Am Rev Respir Dis (1988) 1.48

Thoracocentesis. Clinical value, complications, technical problems, and patient experience. Chest (1987) 1.48

Clinical tools do not predict pathological complete response in patients with esophageal squamous cell cancer treated with definitive chemoradiotherapy. Dis Esophagus (2013) 1.46

Corticosteroids in chronic bronchitis and pulmonary emphysema. Chest (1978) 1.46

Lung resection for colorectal metastases. 10-year results. Arch Surg (1992) 1.44

Pleural effusions in hospitalized patients with AIDS. Ann Intern Med (1993) 1.44

Postoperative fluorescence bronchoscopic surveillance in non-small cell lung cancer patients. Ann Thorac Surg (2001) 1.43

Corticosteroids in acute respiratory failure. Am J Respir Crit Care Med (1999) 1.42

Talc should be used for pleurodesis. Am J Respir Crit Care Med (2000) 1.42

A prospective study of amylase-rich pleural effusions with special reference to amylase isoenzyme analysis. Chest (1992) 1.42

Bullous sarcoidosis: a report of three cases. Chest (1998) 1.42

Sterilization of talc for pleurodesis. Available techniques, efficacy, and cost analysis. Chest (1995) 1.41

A prospective comparison of IMV and T-piece weaning from mechanical ventilation. Chest (1989) 1.41

Immediate chest roentgenography following fiberoptic bronchoscopy. Chest (1989) 1.41

Contribution of videothoracoscopy to the management of the cancer patient. Ann Surg Oncol (1994) 1.40

Elevated levels of platelet derived growth factor and transforming growth factor-beta 1 in bronchoalveolar lavage fluid from patients with scleroderma. J Rheumatol (1995) 1.38

Sarcoidosis presenting as progressive ascending lower extremity weakness and asymptomatic meningitis with hypoglycorrhachia. Chest (1990) 1.38

Cyclophosphamide and low-dose prednisone therapy in patients with systemic sclerosis (scleroderma) with interstitial lung disease. J Rheumatol (1993) 1.38

Small-cell carcinoma of the esophagus and gastroesophageal junction: review of the Memorial Sloan-Kettering experience. Ann Oncol (2007) 1.38

Prospective assessment of 30-day operative morbidity for surgical resections in lung cancer. Chest (1994) 1.35

Predictors of survival in malignant tumors of the sternum. J Thorac Cardiovasc Surg (1996) 1.32

Aspergilloma in sarcoid and tuberculosis. Chest (1987) 1.30

The incidence and clinical correlates of parapneumonic effusions in pneumococcal pneumonia. Chest (1978) 1.27

Extragonadal germ cell tumors. A 14-year Toronto experience. Cancer (1994) 1.27

Pleural disease in pregnancy. Clin Chest Med (1992) 1.26

Tension pneumothorax: diagnostic and therapeutic pitfalls. Crit Care Med (1993) 1.25

Miliary tuberculosis. Am J Med (1974) 1.25

Interstitial lung disease in polymyositis and dermatomyositis: analysis of six cases and review of the literature. Medicine (Baltimore) (1976) 1.24

Pleural effusions in the medical ICU: prevalence, causes, and clinical implications. Chest (1997) 1.23

Technique of successful clinical double-lung transplantation. Ann Thorac Surg (1988) 1.23

Minimally invasive localization of oncolytic herpes simplex viral therapy of metastatic pleural cancer. Cancer Gene Ther (2006) 1.23

Post-extubation pulmonary edema following anesthesia induced by upper airway obstruction. Are certain patients at increased risk? Chest (1986) 1.22

Successful treatment of solitary extracranial metastases from non-small cell lung cancer. Ann Thorac Surg (1995) 1.21

Pleural fluid pH in parapneumonic effusions. Chest (1976) 1.20

Bacillus Calmette-Guérin-stimulated neutrophils release chemotaxins for monocytes in rabbit pleural spaces and in vitro. J Clin Invest (1985) 1.18

Tobramycin solution for inhalation reduces sputum Pseudomonas aeruginosa density in bronchiectasis. Am J Respir Crit Care Med (2000) 1.17

Incidence and outcome of the respiratory distress syndrome in gram-negative sepsis. Arch Intern Med (1979) 1.17

Abdominal manifestations of pulmonary embolism. JAMA (1976) 1.16

Effect of ethanol on the ventilatory responses to oxygen and carbon dioxide in man. Clin Sci Mol Med (1975) 1.16

Surgical implications of the new IASLC/ATS/ERS adenocarcinoma classification. Eur Respir J (2011) 1.16

Analysis of tube thoracostomy performed by pulmonologists at a teaching hospital. Chest (1997) 1.15

The glucose-pH relationship in parapneumonic effusions. Arch Intern Med (1978) 1.15

Wegener granulomatosis with aphasia. Arch Intern Med (1976) 1.15

Induction chemotherapy before surgery for early-stage lung cancer: A novel approach. Bimodality Lung Oncology Team. J Thorac Cardiovasc Surg (2000) 1.15

Staging of malignant pleural mesothelioma: comparison of CT and MR imaging. AJR Am J Roentgenol (1999) 1.14

Emergency room intubations--complications and survival. Chest (1979) 1.14

Scleroderma bronchoalveolar lavage fluid contains thrombin, a mediator of human lung fibroblast proliferation via induction of platelet-derived growth factor alpha-receptor. Am J Respir Cell Mol Biol (1994) 1.14

Acid-base disturbances in acute asthma. Chest (1990) 1.14